HLA-F transcriptional and protein differential expression according to its genetic polymorphisms.
HLA-F
allele
expression
genotype
Journal
HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
21
03
2023
received:
13
12
2022
accepted:
20
04
2023
medline:
10
10
2023
pubmed:
11
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
Many specificities single out HLA-F: its structure, expression regulation at cell membrane and function. HLA-F mRNA is detected in the most cell types and the protein is localized in the ER and Golgi apparatus. When expressed at cell surface, HLA-F may be associated to β2-microglobulin and peptide or expressed as an open-conformer molecule. HLA-F reaches the membrane upon activation of different primary cell types and cell-lines. HLA-F has its highest affinity for the KIR3DS1-activating NK receptor, but also binds inhibitory immune receptors. Some studies reported that HLA-F expression is associated with its genotype. Higher HLA-F mRNA expression associated with F*01:01:02, and 3 noncoding SNPs, rs1362126, rs2523405, and rs2523393, located in HLA-F-AS1 or upstream the HLA-F sequence were associated with HLA-F mRNA expression. Given the implication of HLA-F in many clinical setting, and the undisclosed process of its expression regulation, we aim to confirm the effect of the aforementioned SNPs with HLA-F transcriptional and protein expression. We analyzed the distribution, frequency and linkage disequilibrium of these SNPs at worldwide scale in the 1000 Genomes Project samples. Influence on the genotype of each SNP on HLA-F expression was explored using RNAseq data from the 1000 Genomes Project, and using Q-PCR and intracellular cytometry in PBMC from healthy individuals. Our results show that the SNPs under studied displayed remarkably different allelic proportion according to geography and confirm that rs1362126, rs2523405, and rs2523393 displayed the most concordant results, with the highest effect size and a double-dose effect.
Substances chimiques
HLA-F antigens
0
Histocompatibility Antigens Class I
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
578-589Informations de copyright
© 2023 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.
Références
Carey BS, Poulton KV, Poles A. Factors affecting HLA expression: a review. Int J Immunogenet. 2019;46(5):307-320. doi:10.1111/iji.12443
Norman PJ, Norberg SJ, Guethlein LA, et al. Sequences of 95 human MHC haplotypes reveal extreme coding variation in genes other than highly polymorphic HLA class I and II. Genome Res. 2017;27(5):813-823. doi:10.1101/gr.213538.116
Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48(D1):D948-D955. doi:10.1093/nar/gkz950
Maier S, Grzeschik M, Weiss EH, Ulbrecht M. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells. Hum Immunol. 2000;61(11):1059-1065.
Rizzo R, Bortolotti D, Fredj NB, et al. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol. 2012;73(11):1140-1146. doi:10.1016/j.humimm.2012.08.005
Di Cristofaro J, El Moujally D, Agnel A, et al. HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. Hum Immunol. 2013;74(2):203-206.
Rebmann V, da Silva NF, Wagner B, Horn PA. HLA-G as a Tolerogenic molecule in transplantation and pregnancy. J Immunol Res. 2014;2014:297073. doi:10.1155/2014/297073
Kraemer T, Blasczyk R, Bade-Doeding C. HLA-E: a novel player for histocompatibility. J Immunol Res. 2014;2014:352160. doi:10.1155/2014/352160
Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J Immunol. 2013;191(7):3553-3562. doi:10.4049/jimmunol.1300081
Lepin EJ, Bastin JM, Allan DS, et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol. 2000;30(12):3552-3561. doi:10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L
Foroni I, Couto AR, Bettencourt BF, Santos M, Lima M, Bruges-Armas J. HLA-E, HLA-F and HLA-G - the non-classical side of the MHC cluster. In: Xi Y, ed. HLA and Associated Important Diseases. Intech; 2014 http://www.intechopen.com/books/hla-and-associated-important-diseases/hla-e-hla-f-and-hla-g-the-non-classical-side-of-the-mhc-cluster
Burian A, Wang KL, Finton KA, et al. HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1. PLoS One. 2016;11(9):e0163297. doi:10.1371/journal.pone.0163297
Garcia-Beltran WF, Holzemer A, Martrus G, et al. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol. 2016;17(9):1067-1074. doi:10.1038/ni.3513
Laaribi AB, Hannachi N, Ben Yahia H, et al. Human leukocyte antigen (HLA-F) polymorphism is associated with chronic HBV infection. 3 Biotech. 2018;8(1):49. doi:10.1007/s13205-017-1079-9
Lunemann S, Schobel A, Kah J, et al. Interactions between KIR3DS1 and HLA-F activate natural killer cells to control HCV replication in cell culture. Gastroenterology. 2018;155(5):1366-1371. doi:10.1053/j.gastro.2018.07.019
Kochan G, Escors D, Breckpot K, Guerrero-Setas D. Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology. 2013;2(11):e26491. doi:10.4161/onci.26491
Lee N, Geraghty DE. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol. 2003;171(10):5264-5271.
Hoek M, Demmers LC, Wu W, Heck AJR. Allotype-specific glycosylation and cellular localization of human leukocyte antigen class I proteins. J Proteome Res. 2021;20(9):4518-4528. doi:10.1021/acs.jproteome.1c00466
Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods. 2002;268(1):43-50.
Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail. J Immunol. 2006;176(11):6464-6472.
Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol. 2010;184(11):6199-6208. doi:10.4049/jimmunol.1000078
Dulberger CL, McMurtrey CP, Holzemer A, et al. Human leukocyte antigen F presents peptides and regulates immunity through interactions with NK cell receptors. Immunity. 2017;46(6):1018-1029. doi:10.1016/j.immuni.2017.06.002
Hò G-GT, Hiemisch W, Pich A, Behrens GMN, Blasczyk R, Bade-Doeding C. The loss of HLA-F/KIR3DS1 ligation is mediated by hemoglobin peptides. Int J Mol Sci. 2020;21(21):8012. doi:10.3390/ijms21218012
Hackmon R, Pinnaduwage L, Zhang J, Lye SJ, Geraghty DE, Dunk CE. Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition. Am J Reprod Immunol. 2017;77(6). doi:10.1111/aji.12643
Wainwright SD, Biro PA, Holmes CH. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern. J Immunol. 2000;164(1):319-328. doi:10.4049/jimmunol.164.1.319
Lee N, Ishitani A, Geraghty DE. HLA-F is a surface marker on activated lymphocytes. Eur J Immunol. 2010;40(8):2308-2318.
Heinrichs H, Orr HT. HLA non-a,B,C class I genes: their structure and expression. Immunol Res. 1990;9(4):265-274.
Fiouane S, Chebbo M, Beley S, et al. Mobilisation of HLA-F on the surface of bronchial epithelial cells and platelets in asthmatic patients. HLA. 2022;100:491-499. doi:10.1111/tan.14782
Paganini J, Ramdane A, Gouret P, Chiaroni J, Di Cristofaro J. Validation of new HLA-F alleles assigned by next-generation sequencing. HLA. 2019;93(2-3):131-132. doi:10.1111/tan.13455
Lima THA, Buttura RV, Donadi EA, Veiga-Castelli LC, Mendes-Junior CT, Castelli EC. HLA-F coding and regulatory segments variability determined by massively parallel sequencing procedures in a Brazilian population sample. Hum Immunol. 2016;77(10):841-853. doi:10.1016/j.humimm.2016.07.231
Buttura RV, Ramalho J, Lima THA, et al. HLA-F displays highly divergent and frequent haplotype lineages associated with different mRNA expression levels. Hum Immunol. 2019;80(2):112-119. doi:10.1016/j.humimm.2018.10.016
Burrows CK, Kosova G, Herman C, et al. Expression quantitative trait locus mapping studies in mid-secretory phase endometrial cells identifies HLA-F and TAP2 as Fecundability-associated genes. PLoS Genet. 2016;12(7):e1005858. doi:10.1371/journal.pgen.1005858
Mika KM, Li X, DeMayo FJ, Lynch VJ. An ancient Fecundability-associated polymorphism creates a GATA2 binding site in a distal enhancer of HLA-F. Am J Hum Genet. 2018;103(4):509-521. doi:10.1016/j.ajhg.2018.08.009
Langkilde CH, Nilsson LL, Jorgensen N, et al. Variation in the HLA-F gene locus with functional impact is associated with pregnancy success and time-to-pregnancy after fertility treatment. Hum Reprod. 2020;35(3):705-717. doi:10.1093/humrep/dez276
Papuchova H, Saxtorph MH, Hallager T, et al. Endometrial HLA-F expression is influenced by genotypes and correlates differently with immune cell infiltration in IVF and recurrent implantation failure patients. Hum Reprod. 2022;37(8):1816-1834. doi:10.1093/humrep/deac118
The 1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74. doi:10.1038/nature15393
Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. doi:10.1086/519795
Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512-526. doi:10.1093/oxfordjournals.molbev.a040023
Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38(7):3022-3027. doi:10.1093/molbev/msab120
Abi-Rached L, Gouret P, Yeh JH, et al. Immune diversity sheds light on missing variation in worldwide genetic diversity panels. PLoS One. 2018;13(10):e0206512. doi:10.1371/journal.pone.0206512
Paganini J, Abi-Rached L, Gouret P, Pontarotti P, Chiaroni J, Di Cristofaro J. HLAIb worldwide genetic diversity: new HLA-H alleles and haplotype structure description. Mol Immunol. 2019;112:40-50. doi:10.1016/j.molimm.2019.04.017
Brandt DY, Aguiar VR, Bitarello BD, Nunes K, Goudet J, Meyer D. Mapping bias overestimates reference allele frequencies at the HLA genes in the 1000 genomes project phase I data. G3. 2015;5(5):931-941. doi:10.1534/g3.114.015784
Castelli EC, Paz MA, Souza AS, Ramalho J, Mendes-Junior CT. Hla-mapper: an application to optimize the mapping of HLA sequences produced by massively parallel sequencing procedures. Hum Immunol. 2018;79(9):678-684. doi:10.1016/j.humimm.2018.06.010
Ishitani A, Sageshima N, Lee N, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003;171(3):1376-1384. doi:10.4049/jimmunol.171.3.1376
Hrbac T, Kopkova A, Siegl F, et al. HLA-E and HLA-F are overexpressed in glioblastoma and HLA-E increased after exposure to ionizing radiation. Cancer Genom Proteom. 2022;19(2):151-162. doi:10.21873/cgp.20311
Chen X, Sun N, Li R, et al. Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis. Int J Biol Sci. 2021;17(5):1263-1276. doi:10.7150/ijbs.56357
Dunk CE, Bucher M, Zhang J, et al. Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis. Am J Obstet Gynecol. 2022;227(4):641:e1-e13. doi:10.1016/j.ajog.2022.07.021
Logan JG, Yun S, Teachman BA, Bao Y, Farber E, Farber CR. Genome-wide mRNA expression analysis of acute psychological stress responses. MEDICC Rev. 2022;24(2):35-42. doi:10.37757/mr2022.v24.n2.6